Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25393506

Clinical application of asparaginase activity levels following treatment with pegaspargase.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2015 Jun
First author
Bleyer A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Pediatr Blood Cancer. 2015 Jun;62(6):1115. doi: 10.1002/pbc.25426.
    note
    Source null
    related pmid
    25649118
    relationship
    Comment in
  2. citation
    Pediatr Blood Cancer. 2015 Jun;62(6):1116. doi: 10.1002/pbc.25455.
    note
    Source null
    related pmid
    25732374
    relationship
    Comment in

Authors and identifiers

  1. name
    Bleyer A
    type
    Author
  2. name
    Asselin BL
    type
    Author
  3. name
    Koontz SE
    type
    Author
  4. name
    Hunger SP
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Bleyer A
    type
    Author
  2. name
    Asselin BL
    type
    Author
  3. name
    Koontz SE
    type
    Author
  4. name
    Hunger SP
    type
    Author
bibliography ids
  1. nci-bib-3341449a3c7cf3258d787d23
book metadata
content sha256
5b230078434f93f99c1c6412d6b0bfc7425e8b1bdae672ada3b00e1ed7936ae6
document type
citation
dois
  1. 10.1002/pbc.25299
electronic publication date
display
2014 Nov 12
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25393506
immutable id
pubmed:25393506@5b230078434f93f99c1c6412d6b0bfc7425e8b1bdae672ada3b00e1ed7936ae6
journal
abbreviation
Pediatr Blood Cancer
issn electronic
1545-5017
issn print
1545-5009
issue
6
name
Pediatric blood & cancer
nlm unique id
101186624
pages
1102-5
volume
62
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Pediatr Blood Cancer. 2015 Jun;62(6):1115. doi: 10.1002/pbc.25426.
    note
    Source null
    related pmid
    25649118
    relationship
    Comment in
  2. citation
    Pediatr Blood Cancer. 2015 Jun;62(6):1116. doi: 10.1002/pbc.25455.
    note
    Source null
    related pmid
    25732374
    relationship
    Comment in
outcomes validated
false
pmid
25393506
provenance
batch id
863b068fe5a07222af6a
provider
NCBI PubMed ESummary
record sha256
be07b2c00c5141f310530ac758bb6dc755d1ef41f93b33b117d549d8befb9a80
response sha256
80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
retrieved at
2026-09-09T23:47:07.648963+00:00
publication date
display
2015 Jun
precision
month
year
2015
publication types
  1. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25393506/
title
Clinical application of asparaginase activity levels following treatment with pegaspargase.

Preserved source evidence · Not medical advice